About A2 Biotherapeutics
A2 is dedicated to advancing cancer treatment through pioneering cell therapy. Our T cells target solid tumors with precision, transforming the future of medicine.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $80,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $62,000,000 · Series-B+
- Capital Raise
Raised $71,500,000 · Series-B+
- Capital Raise
Raised $57,000,000 · Series-A
- Milestone
Company founded
Agoura Hills, United States
- Milestone
Website domain registered
a2bio.com
Investors & Backers
Funding History
Founders & Leadership
Agi Hamburger
Senior Director Drug Discovery
Alexander Kamb
Founder
David Lucas
Vice President Operations
Han Xu
Sr Director Technology
Madhavan Balachandran
Independent Director
Michelle Kreke
Vice President, Head of Technical Operations
Press Coverage & Sources
fundraisingfox.com/companies/a2-biotherapeutics
fundraisingfox.com/companies/a2-biotherapeutics-2
endpts.com/scoop-a2-biotherapeutics-raises-62m-for-solid-tumor-cell-therapies/
zpr.io/HACJ3
finsmes.com/2019/11/a2-biotherapeutics-raises-57m-in-series-a-funding.html
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com